Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Adenosine, N-benzoyl-5'-O-[(1,1-dimethylethyl)diphenylsilyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

77244-83-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 77244-83-8 Structure
  • Basic information

    1. Product Name: Adenosine, N-benzoyl-5'-O-[(1,1-dimethylethyl)diphenylsilyl]-
    2. Synonyms:
    3. CAS NO:77244-83-8
    4. Molecular Formula: C33H35N5O5Si
    5. Molecular Weight: 609.757
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 77244-83-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Adenosine, N-benzoyl-5'-O-[(1,1-dimethylethyl)diphenylsilyl]-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Adenosine, N-benzoyl-5'-O-[(1,1-dimethylethyl)diphenylsilyl]-(77244-83-8)
    11. EPA Substance Registry System: Adenosine, N-benzoyl-5'-O-[(1,1-dimethylethyl)diphenylsilyl]-(77244-83-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 77244-83-8(Hazardous Substances Data)

77244-83-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 77244-83-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,2,4 and 4 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 77244-83:
(7*7)+(6*7)+(5*2)+(4*4)+(3*4)+(2*8)+(1*3)=148
148 % 10 = 8
So 77244-83-8 is a valid CAS Registry Number.

77244-83-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[9-[(2R,3R,4S,5R)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]purin-6-yl]benzamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77244-83-8 SDS

77244-83-8Downstream Products

77244-83-8Relevant articles and documents

Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors

Bockman, Matthew R.,Kalinda, Alvin S.,Petrelli, Riccardo,De La Mora-Rey, Teresa,Tiwari, Divya,Liu, Feng,Dawadi, Surendra,Nandakumar, Madhumitha,Rhee, Kyu Y.,Schnappinger, Dirk,Finzel, Barry C.,Aldrich, Courtney C.

, p. 7349 - 7369 (2015/10/05)

Mycobacterium tuberculosis (Mtb), responsible for both latent and symptomatic tuberculosis (TB), remains the second leading cause of mortality among infectious diseases worldwide. Mycobacterial biotin protein ligase (MtBPL) is an essential enzyme in Mtb and regulates lipid metabolism through the post-translational biotinylation of acyl coenzyme A carboxylases. We report the synthesis and evaluation of a systematic series of potent nucleoside-based inhibitors of MtBPL that contain modifications to the ribofuranosyl ring of the nucleoside. All compounds were characterized by isothermal titration calorimetry (ITC) and shown to bind potently with KDs ≤ 2 nM. Additionally, we obtained high-resolution cocrystal structures for a majority of the compounds. Despite fairly uniform biochemical potency, the whole-cell Mtb activity varied greatly with minimum inhibitory concentrations (MIC) ranging from 0.78 to >100 μM. Cellular accumulation studies showed a nearly 10-fold enhancement in accumulation of a C-2′-α analogue over the corresponding C-2′-β analogue, consistent with their differential whole-cell activity.

Semisynthesis of 3′(2′)-O-(aminoacyl)-tRNA derivatives as ribosomal substrate

Cui, Zhiyong,Zhang, Biliang

, p. 297 - 310 (2008/02/08)

An efficient synthesis of (3′-terminally) 3′(2′)-O- aminoacylated pCpA derivatives is described, which could lead to the production of (aminoacyl)-tRNAs following T4 RNA ligase mediated ligation. The tetrahydrofuranyl (thf) group was used as a permanent p

Efficient synthesis of protected 3′-deoxyadenosine and 3′-deoxyguanosine from adenosine and guanosine

Cui, Zhiyong,Zhang, Lei,Zhang, Biliang

, p. 561 - 563 (2007/10/03)

Highly efficient synthesis of protected 3′-deoxyadenosine and 3′-deoxyguanosine from adenosine and guanosine were described. The 2′,3′-diol of protected adenosine and guanosine were reacted with α-acetoxyisobutyryl bromide to yield 9-(2′-O-acetyl-3′-bromo

2',3'-O-phosphonoalkylidene derivatives of ribonucleosides: Synthesis and reactivity

Endova, Magdalena,Masojidkova, Milena,Budesinsky, Milos,Rosenberg, Ivan

, p. 11151 - 11186 (2007/10/03)

A novel type of nucleotide analogues, the 2',3'-O-(1- diethylphosphono)alkylidene derivatives of ribonucleosides was prepared by redox reaction of diethyl chlorophosphite with various nucleoside orthoesters. Some of these compounds undergo interesting rearrangements when treated with nucleophiles. The configuration of the title compounds was determined by 2D-ROESY experiments. Biological activity of partially protected nucleotide analogues is also discussed.

Novel Solid-phase Synthesis of Branched Oligoribonucleotides, including a Substrate for the RNA Debranching Enzyme

Sproat, Brian S.,Beijer, Barbro,Groetli, Morten,Ryder, Ursula,Morand, Kenneth L.,Lamond, Angus I.

, p. 419 - 432 (2007/10/02)

An effective new route for synthesizing branched oligoribionucleotides in the solid phase in the 5' to 3' direction has been developed.This required the synthesis of reversed monomers, viz. protected nucleoside 5'-phosphoramidites bearing 2'-O-Fpmp and 3'

Synthesis of 2′-end modified 2′-5′-adenylate trimers

Engels, Joachim

, p. 4339 - 4342 (2007/10/02)

Trimeric 2′,5′-linked adenylates incorporating deoxyribosides and arabinoside of adenine in the 2′-end were synthesized by the phosphotriester approach using quinoline-8-sulfonyl nitrotriazoline as an effective condensing agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 77244-83-8